AbCellera Biologics Inc.
ABCL | NASDAQ
$12.87
+$0.21 (+1.66%)
Sep 22, 2026, 10:57 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.05M | 8.32M | 44.85M | 8.96M | 17.08M | 4.24M | 5.05M | 6.51M | 7.32M | 9.95M | 9.18M | 6.6M | 10.06M | 12.19M | 21.55M | 101.38M | 45.92M | 316.58M | 139.33M | 5.51M | 27.64M | 202.74M |
Cost of Revenue | n/a | 8.66M | 7.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.55M | 15.04M | 5.21M | 44.64M | 21.89M | n/a | 3.61M | 20.01M |
Gross Profit | 4.05M | -340K | 36.93M | 8.96M | 17.08M | 4.24M | 5.05M | 6.51M | 7.32M | 9.95M | 9.18M | 6.6M | 10.06M | 12.19M | 19.99M | 86.35M | 40.71M | 271.94M | 117.44M | 5.51M | 24.03M | 182.73M |
Operating Income | -62.78M | -57.52M | -28.58M | -76.28M | -49.59M | -62.66M | -72.76M | -93.66M | -93.45M | -54.89M | -66.05M | -54.89M | -51.39M | -64.87M | -37.78M | 37.74M | -8.4M | 224.95M | 81.55M | -28.1M | -7.03M | 158.07M |
Interest Income | n/a | 3.64M | 5.92M | 6.77M | 7.59M | 8.05M | 8.67M | 9.6M | 9.8M | 10.4M | 10.97M | 10.74M | 10.78M | 9.76M | n/a | 5.56M | 1.41M | 665K | n/a | n/a | n/a | n/a |
Pretax Income | -58.97M | -49.54M | -19.5M | -68.77M | -36.34M | -52.98M | -46.83M | -62.63M | -48.19M | -42.75M | -48.6M | -39.28M | -38M | -48.15M | -31.41M | 46.59M | -6.89M | 230.81M | 84.71M | -24.97M | -2.07M | 161.49M |
Net Income | -55.43M | -43.17M | -8.95M | -57.12M | -34.73M | -45.62M | -34.21M | -51.11M | -36.93M | -40.61M | -47.15M | -28.61M | -30.53M | -40.11M | -29.89M | 26.62M | -6.79M | 168.57M | 59.95M | -21.38M | -2.32M | 117.22M |
Selling & General & Admin | 13.85M | 10.52M | 15.42M | 24.96M | 21.99M | 19.07M | 19.16M | 22.28M | 23.33M | 20.72M | 19.07M | 17.84M | 19.36M | 18.91M | 15.71M | 16.88M | 17.53M | 16.64M | 14.72M | 12.49M | 12.5M | 9M |
Research & Development | 45.99M | 46.66M | 50.09M | 55.03M | 39.21M | 42.5M | 46.08M | 40.97M | 40.93M | 39.29M | 48.62M | 37.92M | 36.47M | 52.65M | 28.25M | 26.58M | 26.69M | 26.37M | 17.21M | 17.45M | 15.05M | 12.35M |
Other Expenses | 6.99M | n/a | n/a | 5.25M | 5.47M | 5.33M | 12.57M | 36.92M | 36.52M | 4.84M | 7.54M | 5.74M | 5.61M | 5.51M | 13.82M | 5.15M | 4.89M | 3.99M | 3.96M | 3.67M | 3.52M | 3.31M |
Operating Expenses | 66.83M | 57.18M | 65.52M | 85.23M | 66.67M | 66.9M | 77.81M | 100.17M | 100.78M | 64.85M | 75.23M | 61.49M | 61.45M | 77.07M | 57.77M | 48.61M | 49.1M | 46.99M | 35.88M | 33.6M | 31.07M | 24.66M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 2.91M | 3.01M | 2.84M | 3.14M | 3.14M | 3.14M | 3.37M | 3.1M | 3.47M | 3.84M | 3.77M | 2.69M | 3.09M | 3.12M | 2.37M | 1.83M | 1.22M | 1.3M | 2.58M |
Cost & Expenses | 66.83M | 65.83M | 73.44M | 85.23M | 66.67M | 66.9M | 77.81M | 100.17M | 100.78M | 64.85M | 75.23M | 61.49M | 61.45M | 77.07M | 59.32M | 63.65M | 54.31M | 91.63M | 57.78M | 33.6M | 34.68M | 44.67M |
Income Tax Expense | -3.54M | -6.37M | -10.55M | -11.65M | -1.62M | -7.36M | -12.62M | -11.53M | -11.26M | -2.14M | -1.45M | -10.67M | -7.48M | -8.04M | -1.52M | 19.96M | -101K | 62.24M | 24.76M | -3.59M | 250K | 44.27M |
Shares Outstanding (Basic) | 305.56M | 303.07M | 298.71M | 298.88M | 298.51M | 297.69M | 294.59M | 294.85M | 294.22M | 292.72M | 290.95M | 289.5M | 288.91M | 287.77M | 286.41M | 285.32M | 284.69M | 283.9M | 279.83M | 278.93M | 272.2M | 269.7M |
Shares Outstanding (Diluted) | 305.56M | 303.07M | 298.71M | 298.88M | 298.51M | 297.69M | 294.59M | 294.85M | 294.22M | 292.72M | 290.95M | 289.5M | 288.91M | 287.77M | 301.3M | 315.82M | 284.69M | 311.48M | 314.89M | 278.93M | 272.2M | 320.28M |
EPS (Basic) | -0.18 | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.12 | -0.17 | -0.13 | -0.14 | -0.16 | -0.10 | -0.11 | -0.14 | -0.10 | 0.09 | -0.02 | 0.59 | 0.21 | -0.08 | -0.01 | 0.43 |
EPS (Diluted) | -0.18 | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.12 | -0.17 | -0.13 | -0.14 | -0.16 | -0.10 | -0.11 | -0.14 | -0.10 | 0.08 | -0.02 | 0.54 | 0.19 | -0.08 | -0.01 | 0.37 |
EBITDA | -41.53M | -40.88M | -11.58M | -66.31M | -38.83M | -51.9M | -55.31M | -51.88M | -52.11M | -44.85M | -53.57M | -44.65M | -39.56M | -54.38M | -4.66M | 46.61M | -820K | 235.12M | 94.2M | -19.51M | 1.83M | 165.19M |
EBIT | -58.97M | -49.54M | -19.5M | -73.55M | -45.89M | -58.51M | -69.21M | -90.17M | -90.14M | -51.62M | -62.68M | -52.06M | -46.81M | -61.5M | -20.02M | 39.89M | -6.86M | 230.14M | 89.34M | -23.72M | -2.39M | 161.22M |
Depreciation & Amortization | 17.44M | 8.66M | 7.92M | 7.24M | 7.06M | 6.61M | 13.9M | 38.3M | 38.04M | 6.77M | 9.11M | 7.41M | 7.26M | 7.12M | 15.36M | 6.73M | 6.04M | 4.97M | 4.86M | 4.21M | 4.22M | 3.97M |
Add to Watchlist
Select watchlists to add or remove ABCL